Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-03-04
1998-08-25
Lilling, Herbert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514549, 514723, 554223, 554227, A01N 3702, A01N 3706
Patent
active
057983860
ABSTRACT:
There is disclosed an aqueous formulation for vascularizing ischemic or grafted tissue, comprising an alk-1-enyl glycerol derivative having the formula: ##STR1## wherein R is a straight or branched C.sub.1-24 saturated or unsaturated alkyl or a straight or branched C.sub.1-24 aryl and X and Y each is H or an saturated or unsaturated alkyl group having from 2 to 26 carbon atoms, or a monoglyceride having a C.sub.1-24 ether-linked saturated alkyl in an aqueous buffered pharmaceutical carrier.
REFERENCES:
patent: 3294639 (1966-12-01), Chalmers et al.
patent: 3298906 (1967-01-01), Knowles
patent: 3432602 (1969-03-01), Brohult et al.
patent: 3659022 (1972-04-01), Youngdale et al.
patent: 3888994 (1975-06-01), Wagner et al.
patent: 3952107 (1976-04-01), Shibata
patent: 3978092 (1976-08-01), Ichikawa et al.
patent: 4016212 (1977-04-01), Leimgruber et al.
patent: 4046914 (1977-09-01), Hallgren et al.
patent: 4126702 (1978-11-01), Vanderberghe et al.
patent: 4871768 (1989-10-01), Bistrian et al.
patent: 4874795 (1989-10-01), Yesair
patent: 4897263 (1990-01-01), Hunter
patent: 4943560 (1990-07-01), Wigness et al.
patent: 5011680 (1991-04-01), Suzuki et al.
patent: 5095154 (1992-03-01), Liu
patent: 5173511 (1992-12-01), Brohult et al.
patent: 5183811 (1993-02-01), Masaki et al.
patent: 5227533 (1993-07-01), Plotkin et al.
patent: 5243089 (1993-09-01), Plotkin et al.
patent: 5352440 (1994-10-01), Gilchrest et al.
patent: 5358714 (1994-10-01), Green
patent: 5403833 (1995-04-01), Calne
patent: 5434182 (1995-07-01), Issacs et al.
patent: 5569462 (1996-10-01), Martinson et al.
Chem Abs 67: 508166 Slotboom et al "Chemistry and Physics of Lipids" (1967) 1(3) 192-208.
Chem Abs 67:116521 Serebryakova et al Zh. Org. Khim 3(8) 1412-15 (1967).
Foglia et al., Lipids, vol. 23, No. 5, pp. 430-434, "Oxidation of 1-O-(Alk-1-enyl)-2,3-Di-O-Acylglycerols: Models for Plasmalogen Oxidation", 1988.
Ford et al., American Physiological Society, vol. 258, pp. C30-C36, "Activation of myocardial protein kinase C by plasmalogenic diglycerides", 1990.
Ford et al., J. Biol. Chem., vol. 264, No. 23, Issue of Aug. 16, pp. 13818-13824, "Activation of Protein Kinase C by Naturally Occuring Ether-linked Diglycerides", 1989.
Gigg, R., Ether Lipids: Chemistry and Biology, Ed. By Fred Snyder, Chapter V, pp. 87-108, "The Chemical Synthesis of Plasmalogens", 1972.
Hallgren et al., Chemical Abstracts, vol. 80, No. 120255k, p. 382, "Therapeutic substituted alkyl or alkenyl glyceryl ethers", 1974.
Hanahan, D., Etherlipids: Chemistry and Biology, Ed. By Fred Snyder, Chapter II, pp. 25-29, "Ether-linked lipids: Chemistry and Methods of Measurement", 1972.
Knorr et al., J. Chromatography, vol. 526, pp. 303-318, "Simple method for the analysis of glycerol enol ethers derived from plasmalogens in complex lipid mixtures and subsequent determination of the aldehydic components by gas chromatography-mass spectrometry", 1990.
Lin et al., Lipids, vol. 12, No. 7, pp. 620-625, "Composition of O-Alkyl and O-Alk-1-enyl Moieties in the Glycerolipids of the Human Adrenal", 1977.
Seher et al., Thermal Analysis, vol. 3, Proceedings Third ICTA DAVOS, pp. 109-119, "Characterization of Unusual Lipids by Novel Thermoanalytical Techniques", 1971.
Snyder et al., Cancer Res., vol. 28, pp. 972-978, "The Occurrence and Metabolism of Alyl and Alk-1-enyl Ethers of Glycerol in Transplantable Rat and Mouse Tumors", 1968.
Snyder et al., Cancer Res., vol. 29, pp. 251-257, "Alkyl and Alk-1-enyl Ethers of Glycerol in Lipids from Normal and Neoplastic Human Tissues", 1969.
Su et al., Lipids, vol. 9, No. 3, pp. 208-213, "On the Levels of Alkyl and Alk-1-enyl Glycerolipids in Normal and Neoplastic Tissues: A Method of Quantification", 1974.
Touabi et. al., Biochim. Biophys. Acta, vol. 202, pp. 486-495, "Lipolysis and Potassium Accumulation in Isolated Fat Cells Effect of Insulin and Lipolytic Agents", 1970.
Blank et al., Chemical Abstracts, vol. 82, No. 151647k, p. 238, "Method for the quantitative determination of glycerolipids containing O-alkyl and O-alk-1-enyl moieties", 1975.
Baumann et al., Chemical Abstracts, vol. 70, No. 46750t, p. 261, "1-Alkenyl ethers of glycerol and ethanediol", 1969.
Baumann et al., Chemical Abstracts, vol. 73, No. 41867p, p. 261, "Alkoxylipids. VI. Molecular structures of the neutral alkoxylipids of ratfish liver", 1970.
Chalmers et al., Chemical Abstracts, vol. 67, No. 81324s, p. 7651, "Isolation of .alpha.-glyceryl ethers from marine oils", 1967.
Chernaya et al., Chemical Abstracts, vol. 82, No. 18681a, p. 116, "Synthesis and study of alkyl ethers", 1975.
Gilbertson et al., Chemical Abstracts, vol. 63, No. 9445, "Nonphosphatide fatty acyl esters of alkenyl and alkyl ethers of glycerol", 1963.
Hammond et al., Plast. Reconst. Surg., vol. 91, pp. 316-321, "The Dorsal Skin-Flap Model in the Rat: Factors Influencing Survival," 1993.
Hanahan, Chemical Abstracts, vol. 77, No. 164991q, p. 446, "Ether-linked lipids. Chemistry and methods of measurement", 1972.
Hayashi et al., Chemical Abstracts, vol. 89, No. 212271b, p. 339, "The lipids of marine animals from various habitat depths. VII. Compositions of diacyl glyceryl ethers in the flesh lipids of two deep-sea teleost fish, Seriollela sp. and S. Punctata", 1978.
Snyder, et al., Chemical Abstracts, vol. 69, No. 1348f, p. 128, "The occurrence and metabolism of alkyl and alk--1-enyl ethers of glycerol in transplantable rat and mouse tumors", 1968.
Su, et al., Chemical Abstracts, vol. 81, No. 22741S, p. 199, "Levels of alkyl and alk-1-enyl glycerolipids in normal and neoplastic tissues. Methods of Quantification", 1974.
Titov et al., Chemical Abstracts, vol. 80, No. 120253h, p. 382, "cis-1-Alkenyl ethers of glycerol", 1974.
Vedder et al., Plast. Reconst. Surg., vol. 93, pp. 1035-40, "Improved Survival Rates of Random Flaps in Rabbits with a Monoclonal Antibody That Blocks Leukocyte Adherence," 1994.
Cell Therapeutics Inc.
Faciszewski Stephen
Lilling Herbert J.
Shumate Cynthia L.
LandOfFree
Angiogenic lipid formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiogenic lipid formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiogenic lipid formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36717